The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Using adaptive magnetic resonance image‐guided radiation therapy for treatment of inoperable pancreatic cancer
Open accessAbstract
Background: Adaptive magnetic resonance imaging‐guided radiation therapy (MRgRT) can escalate dose to tumors while minimizing dose to normal tissue. We evaluated outcomes of inoperable pancreatic cancer patients treated using MRgRT with and without dose escalation. Methods: We reviewed 44 patients with inoperable pancreatic cancer treated with MRgRT. Treatments included conventional fractionation, hypofractionation, and stereotactic body radiation therapy. Patients were stratified into high‐dose (biologically effective dose [BED 10] >70) and standard‐dose groups (BED 10 ≤70). Overall survival (OS), freedom from local failure (FFLF) and freedom from distant failure (FFDF) were evaluated using Kaplan‐Meier method. Cox regression was performed to identify predictors of OS. Acute gastrointestinal (GI) toxicity was assessed for 6 weeks after completion of RT. Results: Median follow‐up was 17 months. High‐dose patients (n = 24, 55%) had statistically significant improvement in 2‐year OS (49% vs 30%, P = 0.03) and trended towards significance for 2‐year FFLF (77% vs 57%, P = 0.15) compared to standard‐dose patients (n = 20, 45%). FFDF at 18 months in high‐dose vs standard‐dose groups was 24% vs 48%, respectively (P = 0.92). High‐dose radiation (HR: 0.44; 95% confidence interval [CI]: 0.21‐0.94; P = 0.03) and duration of induction chemotherapy (HR: 0.84; 95% CI: 0.72‐0.98; P = 0.03) were significantly correlated with OS on univariate analysis but neither factor was independently predictive on multivariate analysis. Grade 3+ GI toxicity occurred in three patients in the standard‐dose group and did not occur in the high‐dose group. Conclusions: Patients treated with dose‐escalated MRgRT demonstrated improved OS. Prospective evaluation of high‐dose RT regimens with standardized treatment parameters in inoperable pancreatic cancer patients is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hammel, P., Huguet, F., van Laethem, J.-L., Goldstein, D., Glimelius, B., Artru, P., Borbath, I., Bouché, O., Shannon, J., André, T., et al. (2016) · JAMA · doi:10.1001/jama.2016.4324 · Cited by 1,092
Ferrone, C. R., Marchegiani, G., Hong, T. S., Ryan, D. P., Deshpande, V., McDonnell, E. I., Sabbatino, F., Santos, D. D., Allen, J. N., Blaszkowsky, L. S., et al. (2015) · Annals of Surgery · doi:10.1097/sla.0000000000000867 · Cited by 842
Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer
Koong, A. C., Le, Q. T., Ho, A., Fong, B., Fisher, G., Cho, C., Ford, J., Poen, J., Gibbs, I. C., Mehta, V. K., et al. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2003.11.004 · Cited by 444
Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas
Chang, D. T., Schellenberg, D., Shen, J., Kim, J., Goodman, K. A., Fisher, G. A., Ford, J. M., Desser, T., Quon, A., & Koong, A. C. (2009) · Cancer · doi:10.1002/cncr.24059 · Cited by 379
Krishnan, S., Chadha, A. S., Suh, Y., Chen, H.-C., Rao, A., Das, P., Minsky, B. D., Mahmood, U., Delclos, M. E., Sawakuchi, G. O., et al. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.12.003 · Cited by 372
Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma
Hoyer, M., Roed, H., Sengelov, L., Traberg, A., Ohlhuis, L., Pedersen, J., Nellemann, H., Kiil Berthelsen, A., Eberholst, F., Engelholm, S. A., et al. (2005) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2004.12.022 · Cited by 353
Bohoudi, O., Bruynzeel, A. M. E., Senan, S., Cuijpers, J. P., Slotman, B. J., Lagerwaard, F. J., & Palacios, M. A. (2017) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2017.07.028 · Cited by 318
Self-citationOnline Magnetic Resonance Image Guided Adaptive Radiation Therapy: First Clinical Applications
Acharya, S., Fischer-Valuck, B. W., Kashani, R., Parikh, P., Yang, D., Zhao, T., Green, O., Wooten, O., Li, H. H., Hu, Y., et al. (2016) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2015.10.015 · Cited by 302
Self-citationSchellenberg, D., Kim, J., Christman-Skieller, C., Chun, C. L., Columbo, L. A., Ford, J. M., Fisher, G. A., Kunz, P. L., Van Dam, J., Quon, A., et al. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2010.05.006 · Cited by 253
Mahadevan, A., Miksad, R., Goldstein, M., Sullivan, R., Bullock, A., Buchbinder, E., Pleskow, D., Sawhney, M., Kent, T., Vollmer, C., et al. (2011) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2011.04.045 · Cited by 226
Cited by
MR-guidance in clinical reality: current treatment challenges and future perspectives
Corradini, S., Alongi, F., Andratschke, N., Belka, C., Boldrini, L., Cellini, F., Debus, J., Guckenberger, M., Hörner-Rieber, J., Lagerwaard, F. J., et al. (2019) · Radiation Oncology · doi:10.1186/s13014-019-1308-y · Cited by 356
Self-citationLiang, Y., Schott, D., Zhang, Y., Wang, Z., Nasief, H., Paulson, E., Hall, W., Knechtges, P., Erickson, B., & Li, X. A. (2020) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2020.01.021 · Cited by 90
Simpson, G., Spieler, B., Dogan, N., Portelance, L., Mellon, E. A., Kwon, D., Ford, J. C., & Yang, F. (2020) · Medical Physics · doi:10.1002/mp.14200 · Cited by 51
Self-citation
Metadata
- Authors
- Rudra, S., Jiang, N., Rosenberg, S. A., Olsen, J. R., Roach, M. C., Wan, L., Portelance, L., Mellon, E. A., Bruynzeel, A., Lagerwaard, F., Bassetti, M. F., Parikh, P. J., & Lee, P. P.
- Venue
- Cancer Medicine
- Publisher
- Wiley
- Published
- 2019-04
- Volume
- 8
- Issue
- 5
- Pages
- 2123-2132
- ISSN
- 2045-7634 (ISSN-L)
- OpenAlex
- W2932433038
- Cited by
- 350
- References
- 19
- FWCI
- 38.29
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Using adaptive magnetic resonance image‐guided radiation therapy for treatment of inoperable pancreatic cancer. https://app.cochat.ai/papers/10.1002/cam4.2100
- The paper
- Rudra, S., Jiang, N., Rosenberg, S. A., Olsen, J. R., Roach, M. C., Wan, L., Portelance, L., Mellon, E. A., Bruynzeel, A., Lagerwaard, F., Bassetti, M. F., Parikh, P. J., & Lee, P. P. (2019). Using adaptive magnetic resonance image‐guided radiation therapy for treatment of inoperable pancreatic cancer. Cancer Medicine. https://doi.org/10.1002/cam4.2100
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.